Insider Trading: Edwards Lifesciences Corp (EW)

EW on New York Consolidated

129.90USD
26 Dec 2014
Price Change (% chg)

$-0.85 (-0.65%)
Prev Close
$130.75
Open
$130.93
Day's High
$131.24
Day's Low
$129.56
Volume
256,715
Avg. Vol
943,431
52-wk High
$134.29
52-wk Low
$63.04

Search Stocks
VON SCHACK WESLEY W
Trading Date Type Shares Traded Price Shares Held
6 Nov 2014 Sell 3,655 $123.00 24,118
8 May 2014 Buy 2,342 $0.00 27,773
8 May 2014 Buy 469 $0.00 27,773
14 May 2013 Buy 2,811 $0.00 24,962
14 May 2013 Buy 563 $0.00 24,962
2 May 2013 Buy 1,000 $64.00 21,588
25 Apr 2013 Buy 2,000 $64.95 20,588

Institutional Holders

% Shares Owned: 90.61%
# of Holders: 675
Total Shares Held: 96,926,107
3 Mo. Net Change: -1,481,828
# New Positions: 101
# Closed Positions: 23
# Increased Positions: 292
# Reduced Positions: 231
# Net Buyers: 61

Officers & Directors

Name Age Since Current Position

Michael Mussallem

61 2000 Chairman of the Board, Chief Executive Officer

Scott Ullem

47 2014 Chief Financial Officer, Corporate Vice President

Donald Bobo

52 2007 Corporate Vice President - Heart Valve Therapy

Patrick Verguet

56 2004 Corporate Vice President, Europe, Middle East and Africa

Huimin Wang

57 2010 Corporate Vice President, Japan, Asia Pacific

Larry Wood

48 2007 Corporate Vice President - Transcatheter Valve Replacement

Nicholas Valeriani

54 2014 Director

Mike Bowlin

71 2012 Independent Director

John Cardis

72 2004 Independent Director

Robert Ingram

71 2003 Independent Director

William Link

67 2009 Independent Director

Barbara McNeil

73 2006 Independent Director

Wesley von Schack

69 2012 Presiding Independent Director

David Erickson

Vice President - Investor Relations
Search Stocks